Deleted Tweet from Rep. Anna G. Eshoo

In September 2019, I wrote to the FDA asking them to move quickly to address the potential cancer risk of Zantac (also known by its generic name ranitidine). Zantac is a highly common drug with 15 million prescriptions written annually, including for infants and pregnant women.